About Taysha Gene Therapies, Inc. - Common Stock (TSHA)
Taysha Gene Therapies Inc is a biotechnology company focused on developing and delivering innovative gene therapies for the treatment of various neurological diseases, particularly genetic disorders that impact the central nervous system. By leveraging advanced technologies, Taysha aims to create transformative therapies that address the underlying causes of these diseases, providing hope for patients with limited treatment options. The company's research and development efforts emphasize collaboration with leading academic institutions and experts to advance its pipeline of gene therapy products toward clinical application. Read More
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.
